CIBC World Markets’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $48.3M | Buy |
+506,195
| New | +$49.6M | 0.23% | 57 |
|
|
2025
Q2 | $63M | Buy |
586,157
+8,383
| +1% | +$848K | 0.39% | 33 |
|
|
2025
Q1 | $58.3M | Sell |
577,774
-54,745
| -9% | -$5.51M | 0.46% | 35 |
|
|
2024
Q4 | $56.5M | Buy |
632,519
+32,774
| +5% | +$2.89M | 0.33% | 50 |
|
|
2024
Q3 | $50.3M | Buy |
599,745
+10,286
| +2% | +$811K | 0.36% | 50 |
|
|
2024
Q2 | $45.4M | Buy |
589,459
+42,529
| +8% | +$3.11M | 0.3% | 61 |
|
|
2024
Q1 | $37.5M | Sell |
546,930
-41,548
| -7% | -$2.67M | 0.25% | 68 |
|
|
2023
Q4 | $34M | Buy |
588,478
+107,662
| +22% | +$5.75M | 0.19% | 91 |
|
|
2023
Q3 | $25.4M | Buy |
480,816
+12,337
| +3% | +$647K | 0.25% | 71 |
|
|
2023
Q2 | $25.3M | Sell |
468,479
-214,451
| -31% | -$11.2M | 0.21% | 82 |
|
|
2023
Q1 | $34.2M | Buy |
682,930
+514,540
| +306% | +$24.2M | 0.56% | 34 |
|
|
2022
Q4 | $7.79M | Buy |
168,390
+146,667
| +675% | +$6.35M | 0.05% | 244 |
|
|
2022
Q3 | $841K | Sell |
21,723
-78,075
| -78% | -$3.13M | 0.01% | 385 |
|
|
2022
Q2 | $3.72M | Sell |
99,798
-193,359
| -66% | -$7.87M | 0.03% | 266 |
|
|
2022
Q1 | $13M | Buy |
293,157
+24,413
| +9% | +$1.06M | 0.1% | 143 |
|
|
2021
Q4 | $11.4M | Sell |
268,744
-52,536
| -16% | -$2.21M | 0.06% | 171 |
|
|
2021
Q3 | $13.9M | Buy |
321,280
+222,623
| +226% | +$9.85M | 0.09% | 155 |
|
|
2021
Q2 | $4.22M | Sell |
98,657
-36,447
| -27% | -$1.53M | 0.03% | 289 |
|
|
2021
Q1 | $5.22M | Sell |
135,104
-128,742
| -49% | -$4.87M | 0.03% | 284 |
|
|
2020
Q4 | $9.48M | Buy |
263,846
+91,555
| +53% | +$3.3M | 0.05% | 248 |
|
|
2020
Q3 | $6.58M | Buy |
172,291
+31,993
| +23% | +$1.23M | 0.06% | 258 |
|
|
2020
Q2 | $4.93M | Buy |
140,298
+38,288
| +38% | +$1.38M | 0.05% | 252 |
|
|
2020
Q1 | $3.33M | Sell |
102,010
-62,818
| -38% | -$2.45M | 0.04% | 265 |
|
|
2019
Q4 | $7.45M | Sell |
164,828
-336,147
| -67% | -$14.1M | 0.05% | 313 |
|
|
2019
Q3 | $20.4M | Buy |
500,975
+183,213
| +58% | +$7.76M | 0.19% | 132 |
|
|
2019
Q2 | $13.7M | Sell |
317,762
-14,002
| -4% | -$539K | 0.11% | 210 |
|
|
2019
Q1 | $12.7M | Sell |
331,764
-117,041
| -26% | -$4.47M | 0.1% | 184 |
|
|
2018
Q4 | $15.9M | Buy |
448,805
+66,415
| +17% | +$2.41M | 0.15% | 160 |
|
|
2018
Q3 | $14.7M | Buy |
382,390
+75,741
| +25% | +$2.65M | 0.13% | 171 |
|
|
2018
Q2 | $10M | Buy |
306,649
+51,785
| +20% | +$1.56M | 0.09% | 238 |
|
|
2018
Q1 | $6.96M | Sell |
254,864
-50,963
| -17% | -$1.39M | 0.07% | 237 |
|
|
2017
Q4 | $7.58M | Buy |
305,827
+94,850
| +45% | +$2.62M | 0.05% | 258 |
|
|
2017
Q3 | $6.15M | Sell |
210,977
-98,536
| -32% | -$2.72M | 0.06% | 245 |
|
|
2017
Q2 | $8.58M | Buy |
309,513
+167,131
| +117% | +$4.44M | 0.09% | 216 |
|
|
2017
Q1 | $3.54M | Buy |
142,382
+48,949
| +52% | +$1.19M | 0.03% | 284 |
|
|
2016
Q4 | $2.02M | Buy |
+93,433
| New | +$2.04M | 0.02% | 293 |
|
Other funds holding BSX
CIBC World Markets's BSX Position: Q4 2025 in Review
CIBC World Markets opened a new position in Boston Scientific (BSX) in Q4 2025: 506,195 shares worth $48.3M. The stake represents 0.23% of the portfolio and ranks #57 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in BSX as recently as Q2 2025.
CIBC World Markets first reported a position in BSX in Q4 2016 and has held it in 36 quarters since. The position peaked at $63M in Q2 2025. 1,791 funds tracked by Wall St. Rank hold BSX as of Q4 2025.
- CIBC World Markets held 506,195 shares of Boston Scientific worth $48.3M as of Q4 2025.
- Boston Scientific was a new CIBC World Markets position in Q4 2025.
- Boston Scientific made up 0.23% of CIBC World Markets's portfolio in Q4 2025, its #57 holding.
- CIBC World Markets first reported a position in Boston Scientific in Q4 2016 and has held it in 36 quarters since.
- CIBC World Markets's Boston Scientific position peaked at $63M in Q2 2025.
- 1,791 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.
Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.